Page 2 - Nasdaq Calt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report) released its earnings results on Wednesday. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.02, MarketWatch Earnings reports. The business had revenue of $42.45 million for the quarter, compared to the consensus estimate of $36.24 million. […]

Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report) issued its quarterly earnings results on Wednesday. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.02, MarketWatch Earnings reports. Calliditas Therapeutics AB (publ) had a negative return on equity of 96.43% and a negative net margin […]

Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $0.02, MarketWatch Earnings reports. The firm had revenue of $42.45 million during the quarter, compared to analysts’ expectations of $36.24 million. […]

Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report) is scheduled to release its 12/31/2023 earnings data before the market opens on Wednesday, February 21st. Analysts expect Calliditas Therapeutics AB (publ) to post earnings of ($0.09) per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do […]

Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $25.00, but opened at $24.01. Calliditas Therapeutics AB (publ) shares last traded at $23.85, with a volume of 4,324 shares traded. Wall Street Analyst Weigh In Separately, HC Wainwright reiterated […]